Drug Type Small molecule drug |
Synonyms |
Target |
Action agonists |
Mechanism OOR agonists(Nociceptin receptor agonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic peripheral neuropathic pain | Phase 2 | Hungary | 01 Feb 2012 | |
Diabetic peripheral neuropathic pain | Phase 2 | Poland | 01 Feb 2012 | |
Diabetic peripheral neuropathic pain | Phase 2 | United Kingdom | 01 Feb 2012 | |
Diabetic peripheral neuropathic pain | Phase 2 | Germany | 01 Feb 2012 | |
Neuralgia | Phase 2 | Germany | 01 Feb 2012 | |
Neuralgia | Phase 2 | Hungary | 01 Feb 2012 | |
Neuralgia | Phase 2 | Poland | 01 Feb 2012 | |
Neuralgia | Phase 2 | United Kingdom | 01 Feb 2012 |
Phase 2 | 114 | Matching Placebo (Matching Placebo) | nquuifswlv(jwswjnkmhi) = hmorhangsj upsnaggyjc (eznjxvkzcp, uvblqvgxda - rwbwrzerai) View more | - | 02 Oct 2014 | ||
(GRT6010) | nquuifswlv(jwswjnkmhi) = rkpezytuuy upsnaggyjc (eznjxvkzcp, mumdqlvcwk - vhfcklhjdj) View more |